Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Cervical Cancer

  Free Subscription


01.07.2024

1 ACS Appl Mater Interfaces
1 ACS Nano
3 Anticancer Res
1 Arch Med Res
2 Asian Pac J Cancer Prev
1 Biochem Genet
1 Bioengineering (Basel)
1 Biomedicines
1 BMC Cancer
4 BMC Womens Health
2 BMJ Open
3 Cancers (Basel)
1 Curr Issues Mol Biol
1 Curr Oncol
1 Diagnostics (Basel)
1 Exp Ther Med
1 Expert Opin Biol Ther
1 Front Immunol
1 Front Oncol
1 Front Pharmacol
1 Genomics Inform
1 Gynecol Oncol Rep
1 Health Sci Rep
1 Healthcare (Basel)
1 In Vivo
1 Indian J Community Med
1 Indian J Public Health
2 Int J Gynaecol Obstet
2 Int J Gynecol Cancer
1 Int J Gynecol Pathol
1 Int J Radiat Oncol Biol Phys
1 J Cancer Res Clin Oncol
1 J Ethnopharmacol
3 J Med Virol
1 J Pers Med
1 JCO Glob Oncol
1 Life (Basel)
1 Mar Drugs
2 Medicina (B Aires)
3 Medicina (Kaunas)
1 Microbiol Spectr
1 Minerva Obstet Gynecol
1 Mod Pathol
1 Mol Biotechnol
1 mSphere
1 Nat Med
1 Nat Rev Clin Oncol
1 Nutr Cancer
1 Oncol Lett
1 Oncol Rep
1 Pathol Res Pract
1 Phys Imaging Radiat Oncol
2 PLoS One
1 Radiat Oncol
1 Reprod Health
1 Sci Data
2 Sci Rep
3 Viruses


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    ACS Appl Mater Interfaces

  1. LI H, Du Z, Zhu L, Zhang C, et al
    Ultrabright NIR-IIb Fluorescence Quantum Dots for Targeted Imaging-Guided Surgery.
    ACS Appl Mater Interfaces. 2024;16:32045-32057.
    PubMed         Abstract available


    ACS Nano

  2. CHARGARI C, Maury P, Texier M, Genestie C, et al
    Theragnostic Gadolinium-Based Nanoparticles Safely Augment X-ray Radiation Effects in Patients with Cervical Cancer.
    ACS Nano. 2024 Jun 24. doi: 10.1021/acsnano.3c12537.
    PubMed         Abstract available


    Anticancer Res

  3. ZHANG Y, Niu X, Wang Y, Bao S, et al
    SIRT4 Has an Anti-Cancer Role in Cervical Cancer by Inhibiting Glutamine Metabolism via the MEK/ERK/C-Myc Axis.
    Anticancer Res. 2024;44:2861-2870.
    PubMed         Abstract available

  4. MAFUNE S, Someya M, Hasegawa T, Tsuchiya T, et al
    Analysis of Treatment Response With Proteins Related to Tumor Immunity in Postoperative Irradiated Cervical Cancer Patients.
    Anticancer Res. 2024;44:3077-3086.
    PubMed         Abstract available

  5. CHOI EY, Han EJ, Jeon SJ, Lee SW, et al
    Kaempferol Inhibits Cervical Cancer Cells by Inducing Apoptosis and Autophagy via Inactivation of the PI3K/AKT/mTOR Signaling Pathway.
    Anticancer Res. 2024;44:2961-2972.
    PubMed         Abstract available


    Arch Med Res

  6. DOUBOVA SV, McClellan SP, Martinez-Vega IP, Urena-Bogarin EL, et al
    HPV Self-Sampling in the Workplace: A Qualitative Study of Benefits, Barriers, and Opportunities for Improvement Perceived by Health Professionals and Managers.
    Arch Med Res. 2024;55:103009.
    PubMed         Abstract available


    Asian Pac J Cancer Prev

  7. SHANKAR A, Brixey-Watts K, Roy S, Saini D, et al
    Faking Death for Cervical Cancer Awareness: Is It Justified?
    Asian Pac J Cancer Prev. 2024;25:1851-1853.
    PubMed        

  8. DEGAREGE A, Madhivanan P
    Methodological Assessment of a Review of Knowledge, Attitude and Practice about Human Papilloma Virus Vaccination in India.
    Asian Pac J Cancer Prev. 2024;25:1857-1859.
    PubMed        


    Biochem Genet

  9. YU C, Wang J, Li Y
    TRIM8 Promotes Proliferation, Invasion, and Migration of Cervical Cancer Cells by Ubiquitinating and Degrading SOCS1.
    Biochem Genet. 2024 Jun 25. doi: 10.1007/s10528-024-10865.
    PubMed         Abstract available


    Bioengineering (Basel)

  10. ANDO Y, Cho J, Park NJ, Ko S, et al
    Toward Interpretable Cell Image Representation and Abnormality Scoring for Cervical Cancer Screening Using Pap Smears.
    Bioengineering (Basel). 2024;11:567.
    PubMed         Abstract available


    Biomedicines

  11. VELIMIROVICI MD, Feier CVI, Vonica RC, Faur AM, et al
    Efficacy and Safety of Atezolizumab as a PD-L1 Inhibitor in the Treatment of Cervical Cancer: A Systematic Review.
    Biomedicines. 2024;12:1291.
    PubMed         Abstract available


    BMC Cancer

  12. YANG W, Jin X, Huang L, Jiang S, et al
    Clinical evaluation of an artificial intelligence-assisted cytological system among screening strategies for a cervical cancer high-risk population.
    BMC Cancer. 2024;24:776.
    PubMed         Abstract available


    BMC Womens Health

  13. AGENOR M, Noh M, Eiduson R, LeBlanc M, et al
    Barriers to and opportunities for advancing racial equity in cervical cancer screening in the United States.
    BMC Womens Health. 2024;24:362.
    PubMed         Abstract available

  14. ALCI A, Aytekin O, Ersak B, Kilic F, et al
    The role of neoadjuvant chemotherapy before radical surgery in stage IB2/IIA2 squamous cell cervical cancers.
    BMC Womens Health. 2024;24:365.
    PubMed         Abstract available

  15. WANG J, Wang C, Su T
    Risk factors for residual lesions after total hysterectomy in patients with high-grade cervical intraepithelial neoplasia.
    BMC Womens Health. 2024;24:369.
    PubMed         Abstract available

  16. ZHOU Y, Wang X, Li Y, Zhang W, et al
    When synchronous mucinous metaplasia and neoplasia of the female genital tract and peutz-jeghers syndrome meet: a case report and literature reviews.
    BMC Womens Health. 2024;24:375.
    PubMed         Abstract available


    BMJ Open

  17. BERTELSEN VM, Tranberg M, Petersen LK, Booth B, et al
    Improving diagnostic of cervical dysplasia among postmenopausal women aged >/=50 years using local vaginal oestrogen treatment prior to colposcopy: study protocol for a multicentre randomised controlled trial (the IDEAL study).
    BMJ Open. 2024;14:e082833.
    PubMed         Abstract available

  18. ANDREW-BASSEY UI, Oke DO, Okunlola MA, Morhason-Bello IO, et al
    Scoping review protocol on the perception and attitude of women on methods for collecting cervicovaginal samples for human papillomavirus testing in sub-Saharan Africa.
    BMJ Open. 2024;14:e085408.
    PubMed         Abstract available


    Cancers (Basel)

  19. MIAZGA W, Tatara T, Wnuk K, Gujski M, et al
    The Impact of Urine-Sample HPV Testing on the Effectiveness of Screening for Cervical Cancer: An Umbrella Review.
    Cancers (Basel). 2024;16:2244.
    PubMed         Abstract available

  20. CATALAN-CASTORENA O, Garibay-Cerdenares OL, Illades-Aguiar B, Castillo-Sanchez R, et al
    Bioinformatics Analysis of Human Papillomavirus 16 Integration in Cervical Cancer: Changes in MAGI-1 Expression in Premalignant Lesions and Invasive Carcinoma.
    Cancers (Basel). 2024;16:2225.
    PubMed         Abstract available

  21. CARDOSO-CARNEIRO D, Pinheiro J, Fontao P, Nogueira R, et al
    Unveiling the RKIP and EGFR Inverse Relationship in Solid Tumors: A Case Study in Cervical Cancer.
    Cancers (Basel). 2024;16:2182.
    PubMed         Abstract available


    Curr Issues Mol Biol

  22. ARIZMENDI-IZAZAGA A, Navarro-Tito N, Jimenez-Wences H, Evaristo-Priego A, et al
    Bioinformatics Analysis Reveals E6 and E7 of HPV 16 Regulate Metabolic Reprogramming in Cervical Cancer, Head and Neck Cancer, and Colorectal Cancer through the PHD2-VHL-CUL2-ELOC-HIF-1alpha Axis.
    Curr Issues Mol Biol. 2024;46:6199-6222.
    PubMed         Abstract available


    Curr Oncol

  23. ELIT L, Manjuh F, Kila L, Suika B, et al
    Mother-Child Approach to Cervical Cancer Prevention in a Low Resource Setting: The Cameroon Baptist Convention Health Services Story.
    Curr Oncol. 2024;31:3227-3238.
    PubMed         Abstract available


    Diagnostics (Basel)

  24. KIRSCH-MANGU AT, Pop DC, Tipcu A, Andries AI, et al
    CT Angiography-Guided Needle Insertion for Interstitial Brachytherapy in Locally Advanced Cervical Cancer.
    Diagnostics (Basel). 2024;14:1267.
    PubMed         Abstract available


    Exp Ther Med

  25. CAO D, Dong Q
    Predictive value of prognostic nutritional index for outcomes of cervical cancer: A systematic review and meta?analysis.
    Exp Ther Med. 2024;28:316.
    PubMed         Abstract available


    Expert Opin Biol Ther

  26. FONTENOT VE, Francoeur A, Tewari K
    Review of emerging biological therapies for recurrent and advanced metastatic cervical cancer.
    Expert Opin Biol Ther. 2024 Jun 25. doi: 10.1080/14712598.2024.2373320.
    PubMed        


    Front Immunol

  27. YU JH, Yuan HB, Yan ZY, Zhang X, et al
    The complement regulatory protein CD46 serves as a novel biomarker for cervical cancer diagnosis and prognosis evaluation.
    Front Immunol. 2024;15:1421778.
    PubMed         Abstract available


    Front Oncol

  28. MUHAMMAD ZB, Ezenkwa US, Imoudu IA, Katagum DA, et al
    Cervical cancer awareness, perception, and attitude among tertiary health institution students in northeastern Nigeria.
    Front Oncol. 2024;14:1415627.
    PubMed         Abstract available


    Front Pharmacol

  29. QIN HE, Peng L, Xu YC, Zhang ZX, et al
    GuiErBai: a potent inhibitor, exhibiting broadly antitumor effect against cervical cancer in vitro and in vivo.
    Front Pharmacol. 2024;15:1296588.
    PubMed         Abstract available


    Genomics Inform

  30. AHMADI M, Abdollahi R, Otogara M, Taherkhani A, et al
    Exploring molecular targets: herbal isolates in cervical cancer therapy.
    Genomics Inform. 2024;22:9.
    PubMed         Abstract available


    Gynecol Oncol Rep

  31. SSEDYABANE F, Obuku EA, Namisango E, Ngonzi J, et al
    The diagnostic accuracy of serum and plasma microRNAs in detection of cervical intraepithelial neoplasia and cervical cancer: A systematic review and meta-analysis.
    Gynecol Oncol Rep. 2024;54:101424.
    PubMed         Abstract available


    Health Sci Rep

  32. REZA S, Dewan SMR, Islam MS, Shahriar M, et al
    Response of Bangladesh to the World Health Organization call to eliminate cervical cancer as a public health issue: An observational report.
    Health Sci Rep. 2024;7:e2178.
    PubMed         Abstract available


    Healthcare (Basel)

  33. MATHIS A, Smith UD, Crowther V, Lee T, et al
    An Epidemiological Study of Cervical Cancer Trends among Women with Human Immunodeficiency Virus.
    Healthcare (Basel). 2024;12:1178.
    PubMed         Abstract available


    In Vivo

  34. CHO YA, Park CK, Kim HS
    Ovarian Metastasis from Human Papillomavirus-associated Usual-type Endocervical Adenocarcinoma: Clinicopathological Characteristics for Distinguishing from Primary Ovarian Mucinous or Endometrioid Tumor.
    In Vivo. 2024;38:1973-1983.
    PubMed         Abstract available


    Indian J Community Med

  35. KAUSHAL R, Patel M, Bhardwaj P, Gupta M, et al
    Comparison of Knowledge, Attitude, and Practices of Nursing Staff Regarding Cervical Cancer Screening at Various Levels of Health Care Facilities in Western India.
    Indian J Community Med. 2024;49:529-531.
    PubMed         Abstract available


    Indian J Public Health

  36. AGGARWAL A, Gupta N, Barua M, Jani KK, et al
    Gay and Bisexual Men too should not be Left Out/Deprived of Human Papilloma Virus Vaccination in "Cervical Cancer Elimination Programme" in Countries with a High Prevalence of HIV.
    Indian J Public Health. 2023;67:686.
    PubMed        


    Int J Gynaecol Obstet

  37. ALIABADI AR, Wilailak S, McNally O, Berek JS, et al
    Contraceptive strategies for reducing the risk of reproductive cancers.
    Int J Gynaecol Obstet. 2024 May 9. doi: 10.1002/ijgo.15567.
    PubMed         Abstract available

  38. LIANG C, Su G, Sun L, Zhao H, et al
    Comparison of the clinical outcomes of patients with stage IA-IIA2 cervical adenocarcinoma and squamous cell carcinoma after radical hysterectomy: A propensity score-matched real-world analysis.
    Int J Gynaecol Obstet. 2024 Jan 29. doi: 10.1002/ijgo.15388.
    PubMed         Abstract available


    Int J Gynecol Cancer

  39. GUO XM, Roman LD, Matsuo K
    Considerations for route of hysterectomy in low-risk cervical cancer.
    Int J Gynecol Cancer. 2024 Jun 23:ijgc-2024-005745.
    PubMed        

  40. AGUSTI N, Viveros-Carreno D, Melamed A, Pareja R, et al
    Adjuvant external beam radiotherapy combined with brachytherapy for intermediate-risk cervical cancer.
    Int J Gynecol Cancer. 2024 Jun 25:ijgc-2024-005570.
    PubMed         Abstract available


    Int J Gynecol Pathol

  41. YAZAKI S, Chiba Y, Kojima Y, Yoshida H, et al
    Folate Receptor Alpha Expression and the Tumor Immune Microenvironment in Patients with Cervical Cancer.
    Int J Gynecol Pathol. 2024 Jun 12. doi: 10.1097/PGP.0000000000001051.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  42. CHUK E, Yu C, Scott AA, Liu ZA, et al
    Clinical outcomes of three vs four fractions of MRI-guided brachytherapy in cervical cancer.
    Int J Radiat Oncol Biol Phys. 2024 Jun 25:S0360-3016(24)00745.
    PubMed         Abstract available


    J Cancer Res Clin Oncol

  43. LIU Y, Fang SS, Zhao RS, Liu B, et al
    Nab-paclitaxel plus platinum versus paclitaxel plus platinum as first-line therapy in patients with metastatic or recurrent cervical cancer.
    J Cancer Res Clin Oncol. 2024;150:321.
    PubMed         Abstract available


    J Ethnopharmacol

  44. PENG C, Wang Y, Guo Y, Li J, et al
    A literature review on signaling pathways of cervical cancer cell death-apoptosis induced by Traditional Chinese Medicine.
    J Ethnopharmacol. 2024 Jun 25:118491. doi: 10.1016/j.jep.2024.118491.
    PubMed         Abstract available


    J Med Virol

  45. FOBIAN SF, Mei X, Crezee J, Snoek BC, et al
    Increased human papillomavirus viral load is correlated to higher severity of cervical disease and poorer clinical outcome: A systematic review.
    J Med Virol. 2024;96:e29741.
    PubMed         Abstract available

  46. LOGEL M, El-Zein M, Franco EL, Gonzalez E, et al
    Species-level characterization of the cervicovaginal microbiota and its role in human papillomavirus-associated cervical carcinogenesis.
    J Med Virol. 2024;96:e29764.
    PubMed         Abstract available

  47. ZHAO Q, Yang S, Hao S, Chen Z, et al
    Identification of transcriptionally-active human papillomavirus integrants through nanopore sequencing reveals viable targets for gene therapy against cervical cancer.
    J Med Virol. 2024;96:e29769.
    PubMed         Abstract available


    J Pers Med

  48. PERGIALIOTIS V, Rodolakis I, Rodolakis A, Thomakos N, et al
    Controversies and Advances in the Personalized Surgical Treatment of Cervical Cancer.
    J Pers Med. 2024;14:606.
    PubMed         Abstract available


    JCO Glob Oncol

  49. SHINKAFI-BAGUDU Z
    Renewed Commitments to Eliminate Cervical Cancer: What This Means for Low- and Middle-Income Countries.
    JCO Glob Oncol. 2024;10:e2400147.
    PubMed         Abstract available


    Life (Basel)

  50. DICU-ANDREESCU IG, Marincas MA, Simionescu AA, Dicu-Andreescu I, et al
    Abdominal Parietal Metastasis from Cervical Cancer: A Review of One of the Most Uncommon Sites of Recurrence Including a Report of a New Case.
    Life (Basel). 2024;14:667.
    PubMed         Abstract available


    Mar Drugs

  51. ZHOU D, Chen D, Wu J, Feng T, et al
    Dicerandrol C Suppresses Proliferation and Induces Apoptosis of HepG2 and Hela Cancer Cells by Inhibiting Wnt/beta-Catenin Signaling Pathway.
    Mar Drugs. 2024;22:278.
    PubMed         Abstract available


    Medicina (B Aires)

  52. BECERRA-CANALES B, Campos-Sobrino M, Campos-Sobrino M, Martinez-Munante RD, et al
    [Visual inspection with acetic acid and the control of cervical cancer in primary care].
    Medicina (B Aires). 2024;84:526-533.
    PubMed         Abstract available

  53. MEDINA RUIZ L, Chahla RE, Vega IM, Ortega ES, et al
    [Artificial Intelligence: accuracy for the diagnosis of precancerous lesions of the cervix].
    Medicina (B Aires). 2024;84:459-467.
    PubMed         Abstract available


    Medicina (Kaunas)

  54. NIKOLIC N, Basica B, Strbac M, Terzic L, et al
    Prevalence of Carcinogenic Genotypes of HPV-Infected Women in a Ten-Year Period (2014-2023) in Vojvodina, Serbia.
    Medicina (Kaunas). 2024;60:922.
    PubMed         Abstract available

  55. BALAN L, Secosan C, Sorop VB, Pirtea M, et al
    Impact of SARS-CoV-2 Pandemic on the Diagnosis of Cervical Cancer and Precursor Lesions-A Single-Center Retrospective Study.
    Medicina (Kaunas). 2024;60:909.
    PubMed         Abstract available

  56. DICU-ANDREESCU IG, Marincas MA, Simionescu AA, Dicu-Andreescu I, et al
    The Role of Lymph Node Downstaging Following Neoadjuvant Treatment in a Group of Patients with Advanced Stage Cervical Cancer.
    Medicina (Kaunas). 2024;60:871.
    PubMed         Abstract available


    Microbiol Spectr

  57. CHUNG PYJ, Dhillon SK, Cortoos S, Hamerlinck H, et al
    Evaluation of the Allplex HPV assay's adherence to international guidelines for cervical cancer screening in clinician-collected samples.
    Microbiol Spectr. 2024 Jun 25:e0033224. doi: 10.1128/spectrum.00332.
    PubMed         Abstract available


    Minerva Obstet Gynecol

  58. CALAGNA G, Granese R, Giallombardo V, Capra G, et al
    Attitudes of mothers of preadolescent girls on HPV vaccine in Italy: do we need a turning point?
    Minerva Obstet Gynecol. 2024;76:222-230.
    PubMed         Abstract available


    Mod Pathol

  59. BAI X, Wei J, Starr D, Zhang X, et al
    Assessment of Efficacy and Accuracy of Cervical Cytology Screening With Artificial Intelligence Assistive System.
    Mod Pathol. 2024;37:100486.
    PubMed         Abstract available


    Mol Biotechnol

  60. TUERXUN G, Li W, Abudurexiti G, Zhuo Q, et al
    EPB41L3 Inhibits the Progression of Cervical Cancer Via the ERK/p38 MAPK Signaling Pathway.
    Mol Biotechnol. 2024 Jun 21. doi: 10.1007/s12033-024-01172.
    PubMed         Abstract available


    mSphere

  61. MORGAN EL
    mSphere of Influence: Retreading old ground-the beauty in multi-omic data sets.
    mSphere. 2024;9:e0013124.
    PubMed         Abstract available


    Nat Med

  62. BASU P, Mwanahamuntu M, Pinder LF, Muwonge R, et al
    A portable thermal ablation device for cervical cancer prevention in a screen-and-treat setting: a randomized, noninferiority trial.
    Nat Med. 2024 Jun 25. doi: 10.1038/s41591-024-03080.
    PubMed         Abstract available


    Nat Rev Clin Oncol

  63. MALAGON T, Franco EL, Tejada R, Vaccarella S, et al
    Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination.
    Nat Rev Clin Oncol. 2024;21:522-538.
    PubMed         Abstract available


    Nutr Cancer

  64. WU Q, Zhang L, Sun Y, Ying J, et al
    Vitamin D-Regulated miR-589-3p in Patients with Cervical Cancer Predicts Patient Prognosis and is Involved in Tumor Progression.
    Nutr Cancer. 2024 Jun 24:1-9. doi: 10.1080/01635581.2024.2365473.
    PubMed         Abstract available


    Oncol Lett

  65. AO L, Shi J, Gan J, Yu W, et al
    Effects of dexmedetomidine and ketorolac applied for patient?controlled analgesia on the balance of Th1/Th2 and level of VEGF in patients undergoing laparoscopic surgery for cervical cancer: A randomized controlled trial.
    Oncol Lett. 2024;28:379.
    PubMed         Abstract available


    Oncol Rep

  66. ZHOU Y, Xie Y, Luo Y, Wang S, et al
    SNAI2 enhances HPV?negative cervical cancer cell dormancy by modulating u?PAR expression and the activity of the ERK/p38 signaling pathway in vitro.
    Oncol Rep. 2024;52:104.
    PubMed         Abstract available


    Pathol Res Pract

  67. LIAO W, Li Y, Liu T, Deng J, et al
    The activation of Piezo1 channel promotes invasion and migration via the release of extracellular ATP in cervical cancer.
    Pathol Res Pract. 2024;260:155426.
    PubMed         Abstract available


    Phys Imaging Radiat Oncol

  68. ROUHI R, Niyoteka S, Carre A, Achkar S, et al
    Automatic gross tumor volume segmentation with failure detection for safe implementation in locally advanced cervical cancer.
    Phys Imaging Radiat Oncol. 2024;30:100578.
    PubMed         Abstract available


    PLoS One

  69. NONBOE MH, Napolitano GM, Kann C, Andersen B, et al
    Screening outcome of HPV-vaccinated women: Data from the Danish Trial23 cohort study.
    PLoS One. 2024;19:e0306044.
    PubMed         Abstract available

  70. GONG S, Li G, Li D, Liu Y, et al
    The risk for subsequent primary lung cancer after cervical carcinoma: A quantitative analysis based on 864,627 cases.
    PLoS One. 2024;19:e0305670.
    PubMed         Abstract available


    Radiat Oncol

  71. YANG T, Zhao T, Ji Z, Lei R, et al
    The safety and efficacy of volumetric modulated Arc therapy combined with computer tomography-guided adaptive brachytherapy for locally advanced cervical cancer: a single institution experience.
    Radiat Oncol. 2024;19:77.
    PubMed         Abstract available


    Reprod Health

  72. SACHDEVA M, Datchoua AM, Yakam VF, Kenfack B, et al
    Acceptability of artificial intelligence for cervical cancer screening in Dschang, Cameroon: a qualitative study on patient perspectives.
    Reprod Health. 2024;21:92.
    PubMed         Abstract available


    Sci Data

  73. DILLNER J, Muhr LSA, Kleppe SN, Wang J, et al
    The Swedish Cervical Screening Cohort.
    Sci Data. 2024;11:697.
    PubMed         Abstract available


    Sci Rep

  74. LEE J, Kim DJ, Lee HJ
    Assessment of malignant potential for HPV types 16, 52, and 58 in the uterine cervix within a Korean cohort.
    Sci Rep. 2024;14:14619.
    PubMed         Abstract available

  75. ZHAO Z, Yan P, Zhang X, Yu X, et al
    Causal role of immune cells on cervical cancer onset revealed by two-sample Mendelian randomization study.
    Sci Rep. 2024;14:14890.
    PubMed         Abstract available


    Viruses

  76. CASTRILLO-DIEZ JL, Rivera-Santiago C, Avila-Flores SM, Barrera-Barrera SA, et al
    Findings and Challenges in Replacing Traditional Uterine Cervical Cancer Diagnosis with Molecular Tools in Private Gynecological Practice in Mexico.
    Viruses. 2024;16:887.
    PubMed         Abstract available

  77. GALATI L, Di Bonito P, Marinaro M, Chiantore MV, et al
    HPV16 Phylogenetic Variants in Anogenital and Head and Neck Cancers: State of the Art and Perspectives.
    Viruses. 2024;16:904.
    PubMed         Abstract available

  78. MOSHI JM, Sohaili A, Moafa HN, Hakami AMS, et al
    Short Communication: Understanding the Barriers to Cervical Cancer Prevention and HPV Vaccination in Saudi Arabia.
    Viruses. 2024;16:974.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.